BRCA2 and pachyonychia congenita: BRCA2 germline mutations in men with PC have been associated with an aggressive tumor phenotype, a more advanced tumor stage at the diagnosis and poor survival outcomes at any disease stage, including the localized/locally advanced disease (Tryggvadottir et al., 2007; Castro et al., 2013).